Trustees
Since 31 January 2018, the sole trustee of the Thalidomide Trust has been ‘Thalidomide Trust Company’. The individuals who served as charity trustees before that date now serve as the directors of the trustee company. However, we continue to refer them as trustees internally for continuity and because their role within the Trust remains unchanged. Our current trustees are:
Mark Spofforth OBE, BSC, FCA, CTA, FRSA
Chair of Trustees
Trustee since December 2013
David Body
Vice – Chair of Trustees
Trustee since January 2015
Mark Benstead BA, MBA
Trustee since May 2015
Sir Robert Nelson
Trustee since December 2010
Professor Adrian Newland CBE
Clinical Trustee
Trustee since January 2020
Professor Andrew Owens MD, FRCS(CTh)
Clinical Trustee
Trustee since January 2020
Professor Rosemary Varley
Research Trustee
Trustee since April 2020
Kevin R Wesbroom MA, MA FIA
Trustee since December 2010
Ruthe Isden
Trustee since August 2021